Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow

Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies? Credit available for this activity expires: 11/7/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523